Alexander D. Zeng practices intellectual property law with a focus in patent litigation in medical device technologies. Alexander also practices trademark and copyright enforcement, due diligence, and patent prosecution.
Alexander has experience working on intellectual property matters in industries such as medical devices, food and beverage, consumer goods, fitness, fashion, cryptocurrency, entertainment, and consumer electronics. He has prosecuted medical device patents within the cardiovascular, orthopedic, urology, wound healing, and gastroenterology spaces.
Prior to joining the firm, he worked as a research scientist at USC where he was involved with research on the effect of APOE e4 on brain lipids and at UCLA where he was involved with research with polymeric biomaterials.
He graduated from the University of California Los Angeles with his B.S. in Bioengineering and the University of Southern California with his M.S. in Medical Device and Diagnostic Engineering.
During law school at the University of California Irvine, Alexander was a Research Editor on Law Review and was a member of the UCI Intellectual Property, Art, and Technology clinic where he worked on start-up counseling, trademark prosecution, and fair use analysis for documentary filmmakers.
Extern Experience
Judicial extern under the Honorable James V. Selna in the Central District of California
- Author, Rights holders need to keep faith in standard-essential patents, IAM-Media
- Author, PLI Patent Litigation Treatise from 2019 - Current
Medical Device Blog
-
First Closing of Acutus’s Sale of Its Left-Heart Access Portfolio to Medtronic Completed
-
FDA Breakthrough Device Designation for Biology-Guided Radiotherapy (“BgRT”) Device
- Researchers Develop Face Mask for Detection of SARS-CoV-2
- One-Stop-Shop Apps for COVID-19 Information
- New Motion Sickness Glasses Launched
- Which Supreme Will Reign Supreme: "Legal Counterfeits" in China
- A New Weapon Against Obesity
- Enforcing a Non-Compete Agreement? - One Size Does Not Fit All
- EKG Monitor May Be Included in Future Apple Smart Watches
- Apple, Fitbit Join Pilot Program to Quicken FDA Regulatory Review
- Diabetes Monitoring Technology Moving Toward Consumer Convenience
- FDA Pre-cert Program for Lab-Developed Tests
Litigation Blog
- Intrinsic Evidence Trumps Plain and Ordinary Meaning
- NCAA Rules Limiting Education-Related Benefits Violate Antitrust Laws
- You Missed a Spot: The PTAB Should Consider All Presented Arguments and Evidence in Obviousness Determinations
- Joining an IPR Triggers IPR Estoppel Only for Instituted Grounds
- Broad Claim Language and Unpredictability in the Art Lead to Non-Enablement
- Secondary Consideration of Skepticism Supports Non-Obviousness at PTAB
- Virnetx Inc., v. Apple, Inc.
- BSG Tech LLC v. Buyseasons, Inc.
- Dropplets, Inc. v. E*Trade Bank
- Not All Dupont Factors Are Made Equal
Fashion & Beauty Blog
- Who Owns the Royale With Cheese? - Miramax Sues Tarantino Over the Sale of Pulp Fiction Related NFTs
- Suede Timbs on My Feet Make [Nas’s] Cipher Complete, but Timberland’s Section 2(f) Evidence Was Slacking and Acquired Distinctiveness Was Lacking
- Utility Patents: Another Strategy to Protect Your Beauty and Cosmetic Portfolio
- Keeping up With the Kardashian-[Jenner]’s Trade Secret Battle
- Which Supreme Will Reign Supreme: "Legal Counterfeits" in China